Friday, August 14, 2026
About us Contact us
SUBSCRIBE
BUSINESS

Pandora Pivots to Platinum to Escape Silver Price Swings

The world's largest jeweler is doubling down on platinum-plated pieces to cut its dependence on unpredictable silver markets.

● US Top News and Analysis
BUSINESS

Tim Cook and Howard Lutnick Open Apple Plant in Houston
BUSINESS

China Eyes the Global Halal Market — But Trust Is the Real Trade War
BUSINESS IHG Posts Higher First-Half Profit on US Demand Surge BUSINESS AstraZeneca and Bristol-Myers Held Merger Talks Into Summer BUSINESS Israeli AI Startup Decart Eyes $6B Sale With SpaceX, Amazon Interested BUSINESS AI CEO Slams 38-Hour Workweek as Path to Success
EDITOR'S PICKS
BUSINESS

Israeli AI Startup Decart Eyes $6B Sale With SpaceX, Amazon Interested

SeekingAlpha
 BUSINESS

AI CEO Slams 38-Hour Workweek as Path to Success

fortune (emma burleigh)
 BUSINESS

Outdated Career Rules From Your Parents That Hurt You Now

US Top News and Analysis
 BUSINESS

OpenFX Buys Global Ledger to Launch Multi-Currency Accounts for Fintechs

GlobalNewswire

Business

View all 6 →
BUSINESS

Pandora Pivots to Platinum to Escape Silver Price Swings

The world's largest jeweler is doubling down on platinum-plated pieces to cut its dependence on unpredictable silver markets.

US Top News and Analysis
BUSINESS Tim Cook and Howard Lutnick Open Apple Plant in Houston
US Top News and Analysis
 BUSINESS China Eyes the Global Halal Market — But Trust Is the Real Trade War
MarketWatch.com - Top Stories
 BUSINESS IHG Posts Higher First-Half Profit on US Demand Surge
US Top News and Analysis
 BUSINESS AstraZeneca and Bristol-Myers Held Merger Talks Into Summer
SeekingAlpha
MOST READ
  1. 1 BUSINESS

    Pandora Pivots to Platinum to Escape Silver Price Swings
  2. 2 BUSINESS

    Tim Cook and Howard Lutnick Open Apple Plant in Houston
  3. 3 BUSINESS

    China Eyes the Global Halal Market — But Trust Is the Real Trade War
  4. 4 BUSINESS

    IHG Posts Higher First-Half Profit on US Demand Surge
  5. 5 BUSINESS

    AstraZeneca and Bristol-Myers Held Merger Talks Into Summer

Stay informed.

One concise briefing, weekly. No spam.

By subscribing you agree to receive periodic communications. Unsubscribe anytime via the link in each message or our Unsubscribe page.